Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
6,160.00
+150.00 (2.50%)
Aug 28, 2026, 3:30 PM KST
55.75% (1Y)
| Market Cap | 170.49B +55.8% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 102.09 |
| Forward PE | n/a |
| Dividend | 30.00 (0.49%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 560,447 |
| Open | 6,060.00 |
| Previous Close | 6,010.00 |
| Day's Range | 6,000.00 - 6,270.00 |
| 52-Week Range | 3,500.00 - 15,960.00 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |